OSER1 and rheumatoid arthritis: Based on the results of ROC analysis, OSER1-AS1 levels in serum and synovial tissue could differentiate RA from HCs with better specificity and sensitivity than RF and anti-CCP, and OSER1-AS1 could be used as a potentially promising biomarker for diagnosis and treatment (150).